Health Care Reform

Industry observers said that drug companies are likely to continue to oppose the government's efforts to reduce prices.

On Feb. 1, the CMS will send its initial offer of a fair price for each of the 10 selected prescription drugs to the drugmakers, who have all filed lawsuits attempting to block the government's effort to control drug prices.

At the 42nd annual event for investors, pharma executives and biotech innovators, the spotlight was on AI, the new GLP-1 class of weight loss drugs, non-profit hospitals and treatment for autoimmune disease.

Racial and ethnic earning disparities associated with health insurance premium growth have increased over time.

Shortly after Eli Lilly launched its direct-to-consumer service for its weight loss drug Zepbound, the Mayo Clinic has announced a new telehealth service that will offer direct access to GLP-1 weight-loss medications.

The Centers for Medicare & Medicaid Services has finalized its prior authorization rule – and insurers have to provide a specific reason for denying an urgent medical service request, as well as automate the authorization process.